GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
Molecular Dx Has Your (Copy) Number
CNV Detection and Analysis Tools Are Being Used To Fill Genetic Diagnostic Gaps
For full access to this article login to GEN Select now.
Tonix Targets Reformulation to Create Value
Speedy Drug Delivery Platforms Broaden Indications and Add New Therapeutic Options
- Tonix Pharmaceuticals is staking out its territory in drug reformulations. Drug reformulation enables pharma companies to maximize the value of existing drugs, and also provides an alternative to an orphan drug development strategy for companies seeking an early revenue stream. “Reformulation is essential for getting the most value ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.